TrialNet
Non-Profit & Charitable Organizations · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
220 Hull St Ste 300, Richmond, Virginia,...Phone Number
(804) 783-1139Website
www.trialnet.orgRevenue
$7.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About TrialNet
TrialNet is an international network dedicated to type 1 diabetes (T1D) research, comprising leading academic institutions, healthcare professionals, and scientists. They provide risk screening at no cost for relatives of individuals with T1D and conduct innovative clinical studies aimed at slowing or preventing disease progression. Their mission is to envision a future without T1D by identifying the disease in its earliest stages and collaborating with researchers to advance treatment options. TrialNet operates over 100 screening and study locations worldwide, fostering community engagement and awareness around T1D.Explore more
TrialNet Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TrialNet your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if TrialNet is spiking on competitors!
Check if TrialNet has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once TrialNet has new funding data
Congratulate Masked Content for being promoted to Masked Content at TrialNet
TrialNet, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if TrialNet had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on TrialNet recently announced quarterly report
Product Launch: Get notified when TrialNet launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to TrialNet
Compare insights from companies similar to TrialNet, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TrialNet is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
TrialNet is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about TrialNet.
TrialNet financials insights
Gather financial insights about TrialNet, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
TrialNet Tech Stack
A closer look at the technologies used by TrialNet
TrialNet News & Media
Type 1 diabetes community celebrates research milestone during National Diabetes Month
More than a quarter million people screened for risk SEATTLE, Nov. 14, 2024 /PRNewswire-PRWeb/ -- More than 250,000 people have learned their risk of developing type 1 diabetes (T1D) through TrialNet screening. TrialNet and Breakthrough T1D (formerly JDRF) announced the research milestone...TrialNet Announces Type 1 Diabetes Prevention Breakthrough--
SAN FRANCISCO and NEW YORK, June 9, 2019 /PRNewswire/ -- Researchers are one step closer to preventing type 1 diabetes, thanks to TrialNet research funded by the National Institutes of Health (NIH), primarily through the Special Diabetes Program, with additional support from JDRF, the...Study Finds Low-Dose Anti-Thymocyte Globulin (ATG) Preserves Insulin Production in People Newly Diagnosed With Type 1 Diabetes
ORLANDO, Fla., June 25, 2018 /PRNewswire/ -- Findings from a new TrialNet research study show low-dose thymoglobulin (ATG) slows insulin loss in people newly diagnosed with type 1 diabetes. The findings were presented today at the 2018 American Diabetes Association's Scientific Sessions...
Read more news
Top Non-Profit & Charitable Organizations Companies
Frequently Asked Questions Regarding TrialNet
Sign Up For FreeTo access detailed company insights
TrialNet is an international network dedicated to type 1 diabetes (T1D) research, comprising leading academic institutions, healthcare professionals, and scientists. They provide risk screening at no cost for relatives of individuals with T1D and conduct innovative clinical studies aimed at slowing or preventing disease progression. Their mission i... Read More
